Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total revenue	$ 648,427	$ 460,520
Costs and expenses:
Costs of research and development revenue	404,746	390,762
Research and development	1,342,862	1,808,098
General and administrative	1,655,700	1,554,007
Foreign currency exchange (gain) loss, net	(10,248)	28,272
Total costs and expenses	3,393,060	3,781,139
Loss from operations	(2,744,633)	(3,320,619)
Other income:
Interest income	2,968	25,670
Other income	250,000	0
Total other income	252,968	25,670
Net loss	$ (2,491,665)	$ (3,294,949)
Basic and diluted net loss per common share (in dollars per share)	$ (0.09)	$ (0.12)
Basic and diluted weighted-average common shares outstanding (in shares)	28,251,324	27,533,268
Research and Development [Member]
Revenues:
Total revenue	$ 533,721	$ 460,520
License [Member]
Revenues:
Total revenue	$ 114,706	$ 0